The interplay between cellular plasticity and stemness factors like OCT4, SOX2, and NANOG enables PCa cells to adapt under therapeutic pressure, contributing to tumor heterogeneity, EMT activation, and drug resistance [132]. This evidence concerns the gene NANOG and posterior cortical atrophy.